DUBLIN--(BUSINESS WIRE)--The "Smart in Vitro Diagnostics - Artificial Intelligence for IVD Markets by Application, by Technology and by User with Executive and Consultant Guides" report has been added to ResearchAndMarkets.com's offering.
'Smart in Vitro Diagnostics - Artificial Intelligence for IVD Markets by Application, by Technology and by User with Executive and Consultant Guides'
This report provides data that analysts and planners can use. Hundreds of pages of information including a complete list of United States Medicare Fee Payment Schedules to help understand the new pricing for nucleic acid based tests.
Will Smart Diagnostics replace the physician? Will the power of Artificial Intelligence provide better diagnostics? The market is moving out of a research mode into the clinic. The market is exploding as physicians use all the information they can get to battle disease. While Pharmaceutical Companies see the potential to make nearly any therapy viable. Find out how this new approach to diagnostics will change medical care forever. Learn all about how players are jockeying for position in a market that is being created from scratch. And some players are pulling way out in front and expanding globally. It is a dynamic market situation with enormous opportunity where the right diagnostic with the right support can command premium pricing. And the science is developing at the same time creating new opportunities with regularity. And the cost of many diagnostics continues to fall.
Forecast demand for new testing regimes or technologies. Make research investment decisions. Assistance in providing specific growth and market size estimates for new technology tests is normally provided without additional charges. Existing laboratories and hospitals can use the information directly to forecast and plan for clinical facilities growth. Again, assistance in using the information is normally provided without additional charges.
The report includes detailed breakouts for 18 Countries and 4 Regions. A detailed breakout for any country in the world is available to purchasers of the report.
Vesale Bioscience to Develop AI Phage Therapy Diagnostic Platform
Sepsis Testing Startup DeepUll to Use AI for Medical Decisions Paige to Develop New AI-based Pathology Test
Aiforia Gains CE-IVD Mark for AI-Powered Histopathology Genetic Profiling May Identify Patients Who Do Not Need Radiation Therapy
Genomic Test IDs Cancer Cells Early
Geneseeq to Build Lab for Cancer Profiling in Brazil Illumina Obtains CE-IVD Marking for TSO Comprehensive Assay Guardant Health Receives Medicare Coverage for Guardant360 TissueNextT Test
Labcorp, CCORN Partner for Precision Oncology Celemics, Strand Partner on Integrated Platform for NGS Analysis Burning Rock Revenues Rise
Intermountain and Myriad Combine Test Offering
Guardant Health Turns to Tumor Tissue Sequencing Tempus Inks Oncology Testing Collaboration With Bayer
Biocartis Collaborating With GeneproDx, Endpoint Health on Tests for Idylla Platform Wales to Routinely Screen Cancer Patients With Yourgene Elucigene Test
Foundation Medicine Liquid Biopsy Gets FDA Approval for Multiple Companion Dx
Progress, Challenges in Liquid Biopsy Reimbursement
Israeli Startup Curesponse Raises $6M
Invitae, ArcherDX Merge to Advance Precision Oncology Offerings
MD Anderson Precision Oncology Decision Support to Use Philips' Informatics Solution
FDA Clears Cancer Genomic Profiling Kit From Personal Genome Diagnostics
ArcherDX, Premier Collaborate to Evaluate Genomic Sequencing Assay for Cancers Labs Reporting Cancer Risk Mutations from Tumor Testing Users Begin Integrating Genomics Data for Clinical Decision Support
Fujitsu Improves Efficiency in Cancer Genomic Medicine Instrumentation, Automation and Diagnostic Trends
Traditional Automation and Centralization
The New Automation, Decentralization and Point Of Care
Instruments Key to Market Share
Bioinformatics Plays a Role
Next Generation Sequencing Fuels a Revolution
Whole Genome Sequencing, A Brave New World
Shifting Role of Diagnostics
Players in a Dynamic Market
Diagnostic Test Developer
Chemical/Reagent Supplier
Independent Clinical Laboratory
Public National/regional Laboratory
Physicians Office Lab (POLS)
Chromosomes, Genes and Epigenetics
Gene Panels, Single Gene Assays and Multiplexing
The Cancer Screening Market Opportunity
Cancer Management vs. Diagnosis
The Role of Risk Assessment
Phases of Adoption - Looking into The Future
Structure of Industry Plays a Part
Baylor Miraca Genetics Laboratories
Cytolumina Technologies Corp.
Novogene Bioinformatics Technology Co., Ltd.
For more information about this report visit https://www.researchandmarkets.com/r/8m0z1f-in-vitro?w=4-in-vitro?w=4-in-vitro?w=4
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.